
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CBST | CBOE Canada | CAD | Real-time | |
CBSTF | OTC Markets | USD | Delayed |
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally. The company operates medical and/or adult use marijuana businesses and dispensaries. It also offers flowers, concentrates, edibles, oils and tablets, and accessories under the dreamt, Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brands. In addition, the company provides management services to licensed entities. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The Cannabist Company Holdings Inc. was founded in 2012 and is headquartered in Chelmsford, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Michael James Abbott | 58 | 2019 | Co-Founder & Chairman |
Igor Gimelshtein | 37 | 2019 | Board Observer |
James Aloysius-Charles Kennedy | 71 | 2019 | Independent Director |
Rosemary Mazanet | 69 | 2017 | Director |
Jonathan May | 58 | 2019 | Independent Lead Director |
Julie A. Hill | 79 | 2021 | Independent Director |
David J. Hart | 48 | 2018 | CEO & Director |
John David Howard | 73 | 2020 | Member of the Strategic Advisory Board |
David F. Solomon | 59 | 2020 | Member of the Strategic Advisory Board |
Jeffrey J. Clarke | 63 | 2020 | Independent Director |
Alison Worthington | 60 | 2020 | Independent Director |
Thomas Jerome Lynch | 57 | 2025 | Independent Director |
Peter H. L. Lee | 48 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review